TUESDAY, July 13, 2021 (Healthday News) — Medicare launched a formal process on Monday that will determine whether the agency will cover Aduhelm, the newly approved Alzheimer’s drug whose high price tag and unproven benefits have prompted widespread controversy. Medicare’s announcement came the same day that leaders of two HouseContinue Reading
MONDAY, July 12, 2021 (Healthday News) — The U.S. Food and Drug Administration’s controversial approval of the Alzheimer’s drug Aduhelm should be investigated by the Office of Inspector General (OIG), FDA Acting Commissioner Dr. Janet Woodcock has said. The FDA approved Aduhelm even though an advisory panel of outside expertsContinue Reading
THURSDAY, July 8, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Thursday issued new prescribing rules for the controversial Alzheimer’s medication Aduhelm that will likely limit its use. When first approved a month ago, the FDA said Biogen’s monthly IV drug was for all Alzheimer’s patients. TheContinue Reading
THURSDAY, July 1, 2021 (Healthday News) — The U.S. Food and Drug Administration’s controversial approval of a new Alzheimer’s drug, along with its high price, is now being investigated by two House committees. “We have serious concerns about the steep price of Biogen’s new Alzheimer’s drug Aduhelm and the processContinue Reading
TUESDAY, June 29, 2021 (HealthDay News) — Dementia patients who have the same nurse for all of their home health care visits are a third less likely to be readmitted to the hospital, a new study finds. “While continuity of nursing care may benefit every home health care patient, itContinue Reading
MONDAY, June 28, 2021 (HealthDay News) — Most Americans with dementia are undiagnosed, which shows how important it is to screen and assess seniors for the disease, researchers say. Their new analysis of data from a nationwide survey of about 6 million Americans aged 65 and older revealed that 91%Continue Reading
FRIDAY, June 25, 2021 (Healthday News) — Fresh on the heels of the U.S. Food and Drug Administration’s approval of the controversial Alzheimer’s drug Aduhelm, the maker of a second medicine that works in similar fashion said Thursday it hopes to apply for approval of its medication later this year.Continue Reading
TUESDAY, June 22, 2021 (HealthDay News) — The brains of people who died from COVID-19 were remarkably similar to the brains of people who die from neurodegenerative diseases such as Alzheimer’s and Parkinson’s, showing inflammation and disrupted circuitry, researchers report. “The brains of patients who died from severe COVID-19 showedContinue Reading
THURSDAY, May 27, 2021 (HealthDay News) — The U.S. government and nonprofits are replacing drug companies as the main drivers of Alzheimer’s disease research, two new studies show. The findings are from an analysis of national data by Jeffrey Cummings, a research professor at the University of Nevada, Las VegasContinue Reading
THURSDAY, May 20, 2021 (HealthDay News) — For people worried about developing dementia due to their family history, a preliminary study offers some good news: A healthy lifestyle might curb your risk. Researchers found that older adults with healthy habits had a lower risk of developing dementia, versus the lessContinue Reading